Titan Biotech Limited (TITANBIO.BO)

INR 781.0

(1.07%)

Total Assets Summary of Titan Biotech Limited

Titan Biotech Limited's latest annual total assets in 2023 was 1.56 Billion INR , up 16.4% from previous year.
Titan Biotech Limited's latest quarterly total assets in 2023 FY was 1.56 Billion INR , up 16.4% from previous quarter.
Titan Biotech Limited reported annual total assets of 1.34 Billion INR in 2022, down -6.2% from previous year.
Titan Biotech Limited reported annual total assets of 1.43 Billion INR in 2021, up 42.38% from previous year.
Titan Biotech Limited reported quarterly total assets of 1.42 Billion INR for 2023 Q2, down 0.0% from previous quarter.
Titan Biotech Limited reported quarterly total assets of 1.56 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Titan Biotech Limited (2023 - 2008)

Historical Annual Total Assets of Titan Biotech Limited (2023 - 2008)

Year	Total Assets	Total Assets Growth
2023	1.56 Billion INR	16.4%
2022	1.34 Billion INR	-6.2%
2021	1.43 Billion INR	42.38%
2020	1 Billion INR	32.45%
2019	760.39 Million INR	17.47%
2018	647.29 Million INR	13.94%
2017	568.12 Million INR	8.87%
2016	521.82 Million INR	30.28%
2015	400.54 Million INR	19.54%
2014	335.05 Million INR	20.1%
2013	278.98 Million INR	25.08%
2012	223.03 Million INR	3.54%
2011	215.42 Million INR	41.04%
2010	152.73 Million INR	31.66%
2009	116 Million INR	8.52%
2008	106.89 Million INR	0.0%

Year	Total Assets	Total Assets Growth
2023 Q3	- INR	-100.0%
2023 Q2	1.42 Billion INR	0.0%
2023 Q4	1.56 Billion INR	0.0%
2023 FY	1.56 Billion INR	16.4%
2023 Q1	- INR	-100.0%
2022 Q4	1.34 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	1.23 Billion INR	9.59%
2022 Q1	1.12 Billion INR	-21.28%
2022 FY	1.34 Billion INR	-6.2%
2021 Q2	1.15 Billion INR	0.19%
2021 Q1	1.15 Billion INR	14.47%
2021 FY	1.43 Billion INR	42.38%
2021 Q4	1.43 Billion INR	12.78%
2021 Q3	1.27 Billion INR	10.07%
2020 Q1	940.24 Million INR	23.65%
2020 Q3	950.09 Million INR	-3.39%
2020 FY	1 Billion INR	32.45%
2020 Q4	1 Billion INR	6.01%
2020 Q2	983.45 Million INR	4.6%
2019 Q2	681.33 Million INR	0.0%
2019 FY	760.39 Million INR	17.47%
2019 Q4	760.39 Million INR	0.0%
2018 Q2	606.48 Million INR	0.0%
2018 FY	647.29 Million INR	13.94%
2018 Q4	647.29 Million INR	0.0%
2017 Q4	568.12 Million INR	0.0%
2017 FY	568.12 Million INR	8.87%
2017 Q2	594.89 Million INR	0.0%
2016 Q2	424.56 Million INR	0.0%
2016 FY	521.82 Million INR	30.28%
2016 Q4	521.82 Million INR	0.0%
2015 Q4	400.54 Million INR	0.0%
2015 Q2	331.81 Million INR	0.0%
2015 FY	400.54 Million INR	19.54%
2014 Q4	335.05 Million INR	0.0%
2014 FY	335.05 Million INR	20.1%
2013 FY	278.98 Million INR	25.08%
2013 Q2	253.3 Million INR	0.0%
2013 Q4	278.98 Million INR	0.0%
2012 Q4	223.03 Million INR	0.0%
2012 FY	223.03 Million INR	3.54%
2011 FY	215.42 Million INR	41.04%
2011 Q4	215.42 Million INR	0.0%
2010 FY	152.73 Million INR	31.66%
2010 Q4	152.73 Million INR	0.0%
2009 FY	116 Million INR	8.52%
2008 FY	106.89 Million INR	0.0%
2008 Q4	106.89 Million INR	0.0%

Peer Total Assets Comparison of Titan Biotech Limited

Name	Total Assets	Total Assets Difference
Alfavision Overseas (India) Limited	1.78 Billion INR	12.31%
Biocon Limited	560.7 Billion INR	99.721%
Blue Jet Healthcare Limited	10.58 Billion INR	85.212%
Concord Biotech Limited	17 Billion INR	90.793%
Dishman Carbogen Amcis Limited	95.81 Billion INR	98.366%
FERMENTA BIOTECH LIMITED	5.47 Billion INR	71.418%
GENOMIC VALLEY BIOTECH LIMITED	43.33 Million INR	-3513.1%
Lyka Labs Limited	1.56 Billion INR	0.092%
Panacea Biotec Limited	12.4 Billion INR	87.38%
SAMSRITA LABS LIMITED	155.51 Million INR	-906.861%
Servoteach Industries Limited	1591.00 INR	-98415927.656%
SMS Lifesciences India Limited	3.9 Billion INR	59.905%
Supriya Lifescience Limited	9.21 Billion INR	83.003%
Syngene International Limited	61.51 Billion INR	97.455%
TAKE Solutions Limited	881.05 Million INR	-77.72%
Transgene Biotek Limited	324.4 Million INR	-382.671%
Vanta Bioscience Limited	853.96 Million INR	-83.356%